Prophylactic Ketorolac Post Epiretinal Membrane Surgery
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
Evaluate the efficacy of ketorolac 0.5%, a topical non-steroidal anti-inflammatory drug
(NSAID), to prevent macular edema after epiretinal membrane surgery. Patients undergoing
epiretinal membrane surgery have increased risk of macular swelling which can adversely
affect vision. Since post-intraocular surgery inflammation is a contributing factor to
macular swelling and loss of vision, NSAID drops may be able to prevent or minimize the
deleterious effects of macular swelling after epiretinal membrane surgery.